The concept of innovative drugs fluctuates and rebounds, ALK hits the limit and reaches a historical high

Zhitong
2025.07.18 05:50

In the afternoon, the innovative drug concept fluctuated and rebounded, with high-profile stock ALK hitting the limit up and reaching a new historical high. Previously, Han Commercial Group had two consecutive boards, while Jincheng Pharmaceutical, Olymvax Biopharmaceuticals, and Jiankai Technology rose over 10%. Borui Pharmaceutical, Konruns, Qianhong Bio-pharma, and Jibeier also followed suit

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer